Clinical observation on 60 clinical cases of Qingfei anti-inflammatory pills in treatment of community-acquired pneumonia

[Objective] Observation on Qingfei anti-inflammatory pills in treatment of community-acquired pneumonia(Wind-Warm syndrome, pulmonary syndrome of heat rising). [Methods] The 60 CAP diagnosed patients were randomly divided into two groups, that treatment andcontrast for 30 patients, and all were given Western medicine treatment, in addition. Qingfei anti-inflammatory pills were provided for treatment group. Ten days later, observe the length of time for clinical symptoms and signs lasting or resuming normal, and compare testing indicators of total number of WBC, N%, CRP and absorption of chest infection between two groups before and after treatment.[Results] Total effective rate of treatment group was 96%, while contract group was 90%, so the difference had no statistical significance(P0.05). For the fever, cough, cough phlegm, lung wet rales disappearance time, treatment group was notably shorter, and had significant improvement on CRP, which 10 days later of therapy. The difference had statistical significance(P0.05). But for WBC, N% and absorption of lesion indicated by X-Ray the improvement was similar(P0.05). [Conclusion] Qingfei anti-inflammatory pills combined with Western medicine in the treatment of community-acquired pneumonia(Wind-Warm syndrome, pulmonary syndrome of heat rising) had remarkable effect.